logo
Think you're gluten intolerant? You might be imagining it, study suggests

Think you're gluten intolerant? You might be imagining it, study suggests

Daily Mail​3 days ago
Not all patients with irritable bowel syndrome may be sensitive to gluten, despite numerous studies identifying it as a potential trigger.
According to new research, patients with IBS who have been led to believe that gluten—the protein in wheat products like bread and pasta—triggers their symptoms may have been misled.
According to Canadian researchers, too many IBS patients are restricting themselves to different diets to avoid perceived food triggers—despite not having clearly identified which foods actually worsen their symptoms.
In the study, researchers analysed 28 participants with IBS from McMaster University Digestive Disease clinic, who believed they had a gluten intolerance and as such followed a strict gluten-free diet.
Participants were given cereal bars to eat everyday for a week—made from either purified gluten, whole wheat or gluten-free flour—without knowing which was which.
After completing a week eating one type of cereal bar participants had a two-week break before starting on the next bar, until all three had been trialled.
Researchers found that there was no significant difference in the worsening of symptoms between the three groups, including the gluten-free placebo.
They noted that even after eating the gluten-free control cereal bar, nearly 30 per cent of patients experienced a 50-point worsening of symptoms according to the IBS symptom severity scale.
Professor Premysl Bercik, senior author of the study, concluded: 'Some patients truly have a sensitivity to this food protein, but for many others, it's the belief itself that's driving their symptoms and subsequent choices to avoid gluten-containing foods'.
Despite this, even when participants were informed of the results, most continued to believe that gluten and wheat trigger their symptoms and continued to eat a gluten-free diet.
This in turn could perpetuate symptoms of IBS, leading to malnutrition and lower quality of life, Prof Berick warned.
This is because gluten-free foods typically contain more fat, salt and sugar and less gut-friendly fibre and protein than their equivalents.
Writing in the journal Lancet Gastroenterology and Hepatology, researchers advised that psychological counselling should be incorporated into treatment plans for patients suffering with IBS.
'What we need to improve our clinical management of these patients is to work with them further, not just tell them that gluten is not the trigger and move on.
'Many of them may benefit from psychological support and guidance to help destigmatise gluten and wheat and reintroduce them safely in their diet,' Prof Bercik added.
The researchers added that social media could be behind the trend, with many influencers sharing how eating gluten worsened their symptoms.
Around one in 100 people in the UK suffer coeliac disease, whereby the immune system overreacts to gluten.
What is coeliac disease?
Coeliac disease is a genetic autoimmune disorder in which gluten leads to damage in the small intestine.
Gluten provokes inflammation in the small intestine which affects the body's ability to absorb nutrients from food.
The condition is estimated to affect one in 100 people worldwide.
One percent - or three million Americans - are living with coeliac disease.
There are more than 200 symptoms of coeliac disease but the more common ones are:
Abdominal bloating and pain
Chronic diarrhea
Vomiting
Constipation
Pale, foul-smelling, or fatty stool
Weight loss
Fatigue
The only treatment for the disease is a strict gluten-free diet.
Only foods and beverages with a gluten content less than 20 parts per million are allowed.
Source: Celiac Disease Foundation
But for others, Prof Berick said avoiding gluten could be a coping mechanism.
'Continuing the gluten-free diet might have provided patients with an actionable method to try to control their symptoms, despite the risk of unnecessary diet restrictions.'
Professor Sigrid Elsenbruch, an expert in neurological and behavioral sciences who was not involved in the study, added: 'Changing health-related behaviours is notoriously challenging.
'Persistent dietary choices might reflect the complexity of IBS symptom management rather than an unwillingness to adjust beliefs.'
The researchers of the current study concluded that their findings support the role of psychological factors in symptom responses and dietary behaviours in IBS.
But common limitations of diet studies were observed with lab tests indicating that only around a third of participants followed the gluten-free diet as instructed, and some may have skipped bars altogether to avoid symptoms.
IBS is a common debilitating condition that affects the digestive symptom, causing agonising stomach cramps, bloating, diarrhoea and constipation—with few effective treatments available.
Over time, damage accumulates in the gut, often leading to serious nutrient deficiencies and nerve damage.
The long-term condition is thought to affect around 1 in 5 adults in the UK, but experts say this figure could be much higher.
Around one in 100 people in the UK suffer coeliac disease, whereby the immune system overreacts to gluten.
It's thought that a further 13 per cent of people suffer what's known as non-specific gluten sensitivity (NCGS).
This is when eating the protein triggers unpleasant symptoms like bloating and irregular bowel habits.
Scientists aren't yet sure the reason why some people are affected by this, and some believe it could be due to a nocebo effect — when expecting to suffer symptoms brings them on.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Menstrual cycle data ‘underused' and should be on health records, experts say
Menstrual cycle data ‘underused' and should be on health records, experts say

The Guardian

time18 hours ago

  • The Guardian

Menstrual cycle data ‘underused' and should be on health records, experts say

Menstrual cycle data should be routinely documented by healthcare professionals and researchers as it can be used as an indicator for other health issues, experts have said. This information – which includes cycle length, regularity, intensity, and duration of bleeding – is not routinely collected in healthcare systems or research except when reproductive issues are being assessed. According to experts writing in the Lancet Obstetrics, Gynaecology, & Women's Health, this lack of documentation has resulted in a relatively basic understanding of the impact of menstrual cycles on health, as well as the underdiagnosis and neglect of concerns related to menstruation such as pain and heavy bleeding. These menstrual cycle characteristics can be indicators for conditions such as diabetes, thyroid disorders, polycystic ovarian syndrome, rheumatoid arthritis and irritable bowel syndrome (IBS). In England, information on a patient's menstrual cycle are not routinely collected by healthcare professionals, unlike other measures such as BMI, blood pressure and cholesterol. More than a quarter of women in England are living with a serious reproductive health issue, according to the largest survey of its kind published this year, with experts saying that 'systemic, operational, structural and cultural issues' prevent women from accessing care. Almost a fifth (19%) of women who took part in the study experienced severe period pain in the last year, and 40% of respondents reported heavy menstrual bleeding. Last year, a report by the women and equalities parliamentary committee found that women and girls are enduring years of pain because their reproductive conditions are being dismissed due to 'medical misogyny'. Dr Ranee Thakar, the president of the Royal College of Obstetricians and Gynaecologists, said: 'Serious conditions like fibroids and endometriosis can have a devastating impact on almost every aspect of a person's life, including impacting their physical and mental health, and their ability to work and socialise. 'Too often systemic, operational, structural and cultural issues mean women do not get the care they deserve and our current system risks entrenching the health inequalities we can see in these findings.' The authors of the study concluded: 'The menstrual cycle is an underused but powerful tool for understanding gynaecological and general health. It functions as a vital sign across the lifespan, providing crucial information that can be used to guide and monitor clinical treatment and symptom management, and inform screening and preventive care. 'Recognising the menstrual cycle as an essential health indicator will strengthen health services and impact research across disciplines. Importantly, this recognition will also improve the health of women throughout their lives.' Period-tracking devices have been in demand in recent years, but there are concerns over personal data and information being used by private companies. Public health bodies such as the NHS have been urged to develop their own rival apps to protect data. NHS England have been approached for comment.

Food Network star Anne Burrell's cause of death is revealed five weeks after her shock passing at 55
Food Network star Anne Burrell's cause of death is revealed five weeks after her shock passing at 55

Daily Mail​

time19 hours ago

  • Daily Mail​

Food Network star Anne Burrell's cause of death is revealed five weeks after her shock passing at 55

Food Network star Anne Burrell's cause of death has been revealed, five weeks after her shock death at 55. On Thursday, People confirmed that the celebrity chef tragically died by suicide. Her cause of death was determined as 'acute intoxication due to the combined effects of diphenhydramine, ethanol, cetirizine, and amphetamine' by the New York City medical examiner's office. Per the outlet, 'diphenhydramine and cetirizine are antihistamines, ethanol is a compound found in alcohol and amphetamine is commonly used to treat ADHD.'

Xeljanz for psoriatic arthritis
Xeljanz for psoriatic arthritis

Medical News Today

time20 hours ago

  • Medical News Today

Xeljanz for psoriatic arthritis

Xeljanz (tofacitinib) is a brand-name drug prescribed for psoriatic arthritis. This article covers topics such as side effects, dosage, and how Xeljanz is available in these forms: oral tablet, oral extended-release tablet (Xeljanz XR), and an oral solution. ('Extended release' means the drug contents are slowly released into your body over time.) Throughout this article, we'll use 'Xeljanz' to refer to all forms, except where noted otherwise when specific differences belongs to a drug class called Janus kinase (JAK) inhibitors. The medication is not available in a generic version. Read on for more information about Xeljanz. You can also refer to this in-depth Xeljanz article. Xeljanz has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the 'Before taking Xeljanz' section. Psoriatic arthritis explainedPsoriatic arthritis (PsA) is an autoimmune condition where your body mistakenly attacks your healthy joints. This causes inflammation and can cause permanent joint damage over time without is an autoimmune condition that causes skin cells to rapidly turn over. This creates scaly lesions, called flare-ups, on your skin. About 30% of people with psoriasis also develop PsA. People with PsA typically develop psoriasis symptoms first, although this isn't the case for of psoriatic arthritisSymptoms of psoriatic arthritis will differ for each person and range from mild to general symptoms of psoriatic arthritis include:tender, swollen joints on one or both sides of your bodyswollen fingers or toesjoint stiffness in the morningpain in your muscles and tendonsscaly skin patches that may worsen simultaneously with flaring joint painnails separating from the nail bedflaky scalpfatigueeye painWho Xeljanz is prescribed forXeljanz is prescribed to adults with psoriatic arthritis whose symptoms have not responded to treatment with, or who had intolerable side effects to, one or more tumor necrosis factor (TNF) blockers. Examples of TNF blockers used to treat psoriatic arthritis include:adalimumab (Humira) and its biosimilars, such as adalimumab-ryvk (Simlandi)certolizumab (Cimzia)infliximab (Remicade) and its biosimilars, such as Avsola (infliximab-axxq)golimumab (Simponi and Simponi Aria)How Xeljanz treats psoriatic arthritis Psoriatic arthritis (PsA) is an autoimmune, inflammatory condition. With PsA, your immune system mistakenly attacks your joints, causing pain, inflammation, and other you're prescribed Xeljanz to treat PsA, you may wonder how the medication works to treat your condition. How a drug works is also referred to as its mechanism of way Xeljanz worksXeljanz is a type of medication called a Janus kinase (JAK) inhibitor. It works by blocking an enzyme (a type of protein) called Janus kinase (JAK). The JAK enzyme plays a role in activating certain parts of your immune system, which send signals to increase inflammation that cause psoriatic arthritis (PsA) symptoms. Blocking the JAK enzyme helps decrease inflammation, easing PsA well Xeljanz works for psoriatic arthritisClinical studies found Xeljanz effective for treating psoriatic arthritis (PsA) in adults. These studies specifically evaluated how well Xeljanz worked to treat PsA symptoms in adults whose symptoms did not respond to or who had intolerable side effects to one or more tumor necrosis factor (TNF) way to gauge a medication's effectiveness is through clinical treatment guidelines. Xeljanz is a recommended treatment option for certain adults with psoriatic arthritis in guidelines from the American College of Rheumatology and National Psoriasis Foundation. Your doctor or pharmacist can provide more information on how Xeljanz fits into these treatment Xeljanz for psoriatic arthritisIf you're prescribed Xeljanz for psoriatic arthritis, it's important to understand your dosage and how to take the treating psoriatic arthritis, the following table lists recommended doses for Xeljanz and Xeljanz XR:Xeljanz (oral tablet and oral solution)Xeljanz XR (extended-release oral tablet)Recommended dosage5 milligrams (mg) twice daily11 mg once dailyYour doctor may adjust your Xeljanz dosage if you take certain other medications, have certain medical conditions, or experience certain side effects. To learn more, talk with your doctor or pharmacist. You can also learn more in the prescribing information for Xeljanz and Xeljanz In addition to treating psoriatic arthritis, Xeljanz has other uses. Keep in mind that the drug's dosage may differ when treating other conditions. To learn more, talk with your to take XeljanzXeljanz is available in three forms: oral tabletoral extended-release* tablet (Xeljanz XR)oral solutionYou may take Xeljanz or Xeljanz XR with or without XR extended-release oral tablets should be swallowed whole. Do not chew, crush, or split Xeljanz XR tablets.* 'Extended release' means the drug contents are slowly released into your body over often to take XeljanzIf you're prescribed Xeljanz oral tablet or oral solution, you'll likely take Xeljanz twice per day. Xeljanz XR extended-release tablets are usually taken once per more information about dosing schedules for Xeljanz, see this Xeljanz dosage side effects The use of Xeljanz for psoriatic arthritis may cause side effects that are mild or serious. Xeljanz is also approved to treat the following conditions: rheumatoid arthritis (RA)ankylosing spondylitis (AS)ulcerative colitispolyarticular juvenile idiopathic arthritis (JIA) It's important to note that side effects from Xeljanz may differ slightly depending on the condition it's used to lists below include some of the main side effects that have been reported with Xeljanz. For information about other potential side effects of the drug, talk with your doctor or pharmacist. You can also see our side effect article about Xeljanz or refer to Xeljanz's prescribing After the Food and Drug Administration (FDA) approves a drug, it tracks and reviews side effects of the medication. Sharing your experience helps make medications safer for everyone by giving doctors and researchers more information about how the drug works in real life. If you develop a side effect while taking Xeljanz and want to tell the FDA about it, visit MedWatch or call side effects of XeljanzMild side effects reported by people who took Xeljanz to treat psoriatic arthritis in clinical trials include:upper respiratory infection, such as sinusitisrunny nose, coughing, and sneezingdiarrheaheadacheinsomniafatigueabdominal painindigestionnausea and vomitingincreased cholesterol levelsThese side effects of Xeljanz may be temporary, lasting a few days to weeks. But if they last longer than this, bother you, or become severe, it's important to talk with your doctor or side effects of XeljanzWhile not common, serious side effects with Xeljanz are possible. These include:blood cell problems, including: low lymphocyte countlow neutrophil countlow red blood cell count (anemia)high blood pressureincreased liver enzymes, which can be a sign of drug-induced liver damageperforations (holes) in your stomach or intestinesrisk of serious infection*increased risk of death in certain people*risk of cancer and lymphoproliferative disorders*risk of serious cardiovascular side effects, in certain people*risk of blood clots*Call your doctor right away if you develop serious side effects while using Xeljanz. If the side effects seem life threatening or you think you're having a medical emergency, call 911 or your local emergency number immediately.* Xeljanz has a boxed warning for this side effect. A boxed warning is the most serious warning from the FDA. To learn more, see the 'Before taking Xeljanz' section. ALLERGIC REACTIONFor some people, Xeljanz can cause an allergic general, symptoms of allergic reaction can be mild or to manageFor mild allergic reaction symptoms, such as a mild rash, call your doctor right away. They may recommend treatments to help manage your symptoms. They'll also let you know whether you should keep taking the severe allergic reaction symptoms, such as swelling or trouble breathing, call 911 or your local emergency number right away. These symptoms require immediate medical care as they can become life threatening. If you've had a serious allergic reaction to Xeljanz drug, your doctor may recommend a different medication taking XeljanzBefore you take Xeljanz, there's some important information to keep in mind. The drug may not be a safe option if you have certain medical conditions or other factors that affect your health. Some of these are mentioned warningsThis drug has boxed warnings about the risk for serious infections, an increased risk of death in certain people, risk of cancer, risk of serious cardiovascular side effects in certain people, and the risk of blood clots. These are the most serious warnings from the Food and Drug Administration (FDA).Risk of serious infection: Treatment with Xeljanz lowers the ability of your immune system to fight off infections. This can raise your risk for serious infections, including herpes zoster (shingles) and tuberculosis (TB). Before you begin taking Xeljanz, your doctor will test you for TB. If you have TB or another infection, your doctor may want to treat it before you begin taking Xeljanz. If you develop symptoms of an infection while taking Xeljanz, immediately let your doctor know. They may want to pause your Xeljanz treatment until the infection risk of death in certain people: In studies, people with rheumatoid arthritis (RA) who were age 50 or older, had at least one cardiovascular risk (heart and blood vessel) factor, and took Xeljanz had a small but increased risk of death compared to people receiving tumor necrosis factor (TNF) blocker therapy. Your doctor can assess the benefits and risks of Xeljanz treatment and discuss this with you before you begin taking the medication. Due to this risk, your doctor likely will not prescribe a Xeljanz dosage of 10 milligrams (mg) twice per day or a Xeljanz XR dosage of 22 mg once per day to treat your psoriatic of cancer and lymphoproliferative disorders: Lymphoma and other types of cancer have been reported in studies of people taking Xeljanz. This risk may be higher if you use tobacco or have in the past. Taking Xeljanz can also increase the risk for lymphoproliferative disorders if you've received a kidney transplant and take certain other medications that decrease immune system of this risk, your doctor likely will not prescribe a Xeljanz dosage of 10 mg twice per day or a Xeljanz XR dosage of 22 mg once per day to treat your psoriatic your doctor if you have or have had cancer before you start taking Xeljanz. They can determine whether Xeljanz is safe for you to of serious cardiovascular side effects, in certain people: According to studies where Xeljanz was used to treat rheumatoid arthritis, certain people may have an increased risk of serious cardiovascular side effects from taking the medication. These side effects include heart attack and stroke. To help lower your risk for these side effects, your doctor likely will not prescribe a Xeljanz dosage of 10 mg twice per day or a Xeljanz XR dosage of 22 mg once per day to treat your psoriatic arthritis. If you experience serious cardiovascular side effects during treatment, your doctor will likely have you stop taking sure to tell your doctor if you've had a heart attack or stroke in the past before you begin treatment with Xeljanz. You're also at higher risk for serious cardiovascular side effects from taking Xeljanz if you use tobacco or have in the past. Having heart problems, including heart disease, can also increase this of blood clots: Treatment with Xeljanz may increase your risk for blood clots. Due to this risk, your doctor likely will not prescribe a Xeljanz dosage of 10 mg twice per day or a Xeljanz XR dosage of 22 mg once per day to treat your psoriatic arthritis. Get immediate medical treatment if you think you have symptoms of a blood clot while taking Xeljanz. If you experience this side effect, your doctor will likely have you stop taking you begin taking Xeljanz, let your doctor know if you have a blood clot or have had one in the past. If this applies to you, or you have other risk factors for blood clots, your doctor may prescribe a different treatment for psoriatic warningsIn addition to boxed warnings, Xeljanz has other warnings. If any of the following medical conditions or other health factors are relevant to you, talk with your doctor before taking Xeljanz:if you use or have used tobaccoif you have liver problemsif you have kidney problemsif you have or have had diverticulitisif you have or have had ulcers in your stomach or intestinesif you currently have abdominal painif you have recently received or are scheduled to receive a vaccinepregnant or breastfeedingalcohol consumptionif you've had an allergic reaction to Xeljanz or any of its ingredientsFrequently asked questionsBelow are answers to some frequently asked questions about psoriatic arthritis, does Xeljanz have other indications?Yes, Xeljanz does have other indications besides psoriatic arthritis. (An indication refers to the condition or conditions that a drug is approved to treat.)Besides psoriatic arthritis, other Xeljanz indications include:rheumatoid arthritis (RA)ankylosing spondylitis (AS)ulcerative colitispolyarticular juvenile idiopathic arthritis (JIA)Talk with your doctor or pharmacist if you have questions about the conditions Xeljanz is approved to Xeljanz come as an injection?No, Xeljanz isn't available as an injection. Xeljanz is available in these forms: oral tablet, oral extended-release tablet (Xeljanz XR), and an oral are injectable medications for psoriatic arthritis available. Your doctor or pharmacist can provide more information if you'd like to learn how they compare to cost and coupons The cost of Xeljanz is based on several factors. These include your prescribed treatment regimen, your insurance plan, the pharmacy you use, and your is a brand-name drug that currently is not available as a generic. Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store